Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations

Guillaume Vogt, Ariane Chapgier, Kun Yang, Nadia Chuzhanova, Jacqueline Feinberg, Claire Fieschi, Stéphanie Boisson-Dupuis, Alexandre Alcais, Orchidée Filipe-Santos, Jacinta Bustamante, Ludovic De Beaucoudrey, Ibrahim Al-Mohsen, Sami Al-Hajjar, Abdulaziz Al-Ghonaium, Parisa Adimi, Mehdi Mirsaeidi, Soheila Khalilzadeh, Sergio Rosenzweig, Oscar De La Galle Martin, Thomas R. Bauer & 12 others Jennifer M. Puck, Hans D. Ochs, Dieter Furthner, Carolin Engelhorn, Bernd Belohradsky, Davood Mansouri, Steven M. Holland, Robert D. Schreiber, Laurent Abel, David N. Cooper, Claire Soudais, Jean Laurent Casanova

Research output: Contribution to journalArticle

154 Citations (Scopus)

Abstract

Mutations involving gains of glycosylation have been considered rare, and the pathogenic role of the new carbohydrate chains has never been formally established. We identified three children with mendelian susceptibility to mycobacterial disease who were homozygous with respect to a missense mutation in IFNGR2 creating a new N-glycosylation site in the IFNγR2 chain. The resulting additional carbohydrate moiety was both necessary and sufficient to abolish the cellular response to IFNγ. We then searched the Human Gene Mutation Database for potential gain-of-N-glycosylation missense mutations; of 10,047 mutations in 577 genes encoding proteins trafficked through the secretory pathway, we identified 142 candidate mutations (∼1.4%) in 77 genes (∼13.3%). Six mutant proteins bore new N-linked carbohydrate moieties. Thus, an unexpectedly high proportion of mutations that cause human genetic disease might lead to the creation of new N-glycosylation sites. Their pathogenic effects may be a direct consequence of the addition of N-linked carbohydrate.

Original languageEnglish (US)
Pages (from-to)692-700
Number of pages9
JournalNature Genetics
Volume37
Issue number7
DOIs
StatePublished - 2005
Externally publishedYes

Fingerprint

Glycosylation
Mutation
Carbohydrates
Missense Mutation
Inborn Genetic Diseases
Secretory Pathway
Medical Genetics
Mutant Proteins
Genes
Databases
Proteins

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Vogt, G., Chapgier, A., Yang, K., Chuzhanova, N., Feinberg, J., Fieschi, C., ... Casanova, J. L. (2005). Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations. Nature Genetics, 37(7), 692-700. https://doi.org/10.1038/ng1581

Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations. / Vogt, Guillaume; Chapgier, Ariane; Yang, Kun; Chuzhanova, Nadia; Feinberg, Jacqueline; Fieschi, Claire; Boisson-Dupuis, Stéphanie; Alcais, Alexandre; Filipe-Santos, Orchidée; Bustamante, Jacinta; De Beaucoudrey, Ludovic; Al-Mohsen, Ibrahim; Al-Hajjar, Sami; Al-Ghonaium, Abdulaziz; Adimi, Parisa; Mirsaeidi, Mehdi; Khalilzadeh, Soheila; Rosenzweig, Sergio; De La Galle Martin, Oscar; Bauer, Thomas R.; Puck, Jennifer M.; Ochs, Hans D.; Furthner, Dieter; Engelhorn, Carolin; Belohradsky, Bernd; Mansouri, Davood; Holland, Steven M.; Schreiber, Robert D.; Abel, Laurent; Cooper, David N.; Soudais, Claire; Casanova, Jean Laurent.

In: Nature Genetics, Vol. 37, No. 7, 2005, p. 692-700.

Research output: Contribution to journalArticle

Vogt, G, Chapgier, A, Yang, K, Chuzhanova, N, Feinberg, J, Fieschi, C, Boisson-Dupuis, S, Alcais, A, Filipe-Santos, O, Bustamante, J, De Beaucoudrey, L, Al-Mohsen, I, Al-Hajjar, S, Al-Ghonaium, A, Adimi, P, Mirsaeidi, M, Khalilzadeh, S, Rosenzweig, S, De La Galle Martin, O, Bauer, TR, Puck, JM, Ochs, HD, Furthner, D, Engelhorn, C, Belohradsky, B, Mansouri, D, Holland, SM, Schreiber, RD, Abel, L, Cooper, DN, Soudais, C & Casanova, JL 2005, 'Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations', Nature Genetics, vol. 37, no. 7, pp. 692-700. https://doi.org/10.1038/ng1581
Vogt G, Chapgier A, Yang K, Chuzhanova N, Feinberg J, Fieschi C et al. Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations. Nature Genetics. 2005;37(7):692-700. https://doi.org/10.1038/ng1581
Vogt, Guillaume ; Chapgier, Ariane ; Yang, Kun ; Chuzhanova, Nadia ; Feinberg, Jacqueline ; Fieschi, Claire ; Boisson-Dupuis, Stéphanie ; Alcais, Alexandre ; Filipe-Santos, Orchidée ; Bustamante, Jacinta ; De Beaucoudrey, Ludovic ; Al-Mohsen, Ibrahim ; Al-Hajjar, Sami ; Al-Ghonaium, Abdulaziz ; Adimi, Parisa ; Mirsaeidi, Mehdi ; Khalilzadeh, Soheila ; Rosenzweig, Sergio ; De La Galle Martin, Oscar ; Bauer, Thomas R. ; Puck, Jennifer M. ; Ochs, Hans D. ; Furthner, Dieter ; Engelhorn, Carolin ; Belohradsky, Bernd ; Mansouri, Davood ; Holland, Steven M. ; Schreiber, Robert D. ; Abel, Laurent ; Cooper, David N. ; Soudais, Claire ; Casanova, Jean Laurent. / Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations. In: Nature Genetics. 2005 ; Vol. 37, No. 7. pp. 692-700.
@article{7b94e905fd3c42f3969f55a4ea6dcbdc,
title = "Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations",
abstract = "Mutations involving gains of glycosylation have been considered rare, and the pathogenic role of the new carbohydrate chains has never been formally established. We identified three children with mendelian susceptibility to mycobacterial disease who were homozygous with respect to a missense mutation in IFNGR2 creating a new N-glycosylation site in the IFNγR2 chain. The resulting additional carbohydrate moiety was both necessary and sufficient to abolish the cellular response to IFNγ. We then searched the Human Gene Mutation Database for potential gain-of-N-glycosylation missense mutations; of 10,047 mutations in 577 genes encoding proteins trafficked through the secretory pathway, we identified 142 candidate mutations (∼1.4{\%}) in 77 genes (∼13.3{\%}). Six mutant proteins bore new N-linked carbohydrate moieties. Thus, an unexpectedly high proportion of mutations that cause human genetic disease might lead to the creation of new N-glycosylation sites. Their pathogenic effects may be a direct consequence of the addition of N-linked carbohydrate.",
author = "Guillaume Vogt and Ariane Chapgier and Kun Yang and Nadia Chuzhanova and Jacqueline Feinberg and Claire Fieschi and St{\'e}phanie Boisson-Dupuis and Alexandre Alcais and Orchid{\'e}e Filipe-Santos and Jacinta Bustamante and {De Beaucoudrey}, Ludovic and Ibrahim Al-Mohsen and Sami Al-Hajjar and Abdulaziz Al-Ghonaium and Parisa Adimi and Mehdi Mirsaeidi and Soheila Khalilzadeh and Sergio Rosenzweig and {De La Galle Martin}, Oscar and Bauer, {Thomas R.} and Puck, {Jennifer M.} and Ochs, {Hans D.} and Dieter Furthner and Carolin Engelhorn and Bernd Belohradsky and Davood Mansouri and Holland, {Steven M.} and Schreiber, {Robert D.} and Laurent Abel and Cooper, {David N.} and Claire Soudais and Casanova, {Jean Laurent}",
year = "2005",
doi = "10.1038/ng1581",
language = "English (US)",
volume = "37",
pages = "692--700",
journal = "Nature Genetics",
issn = "1061-4036",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations

AU - Vogt, Guillaume

AU - Chapgier, Ariane

AU - Yang, Kun

AU - Chuzhanova, Nadia

AU - Feinberg, Jacqueline

AU - Fieschi, Claire

AU - Boisson-Dupuis, Stéphanie

AU - Alcais, Alexandre

AU - Filipe-Santos, Orchidée

AU - Bustamante, Jacinta

AU - De Beaucoudrey, Ludovic

AU - Al-Mohsen, Ibrahim

AU - Al-Hajjar, Sami

AU - Al-Ghonaium, Abdulaziz

AU - Adimi, Parisa

AU - Mirsaeidi, Mehdi

AU - Khalilzadeh, Soheila

AU - Rosenzweig, Sergio

AU - De La Galle Martin, Oscar

AU - Bauer, Thomas R.

AU - Puck, Jennifer M.

AU - Ochs, Hans D.

AU - Furthner, Dieter

AU - Engelhorn, Carolin

AU - Belohradsky, Bernd

AU - Mansouri, Davood

AU - Holland, Steven M.

AU - Schreiber, Robert D.

AU - Abel, Laurent

AU - Cooper, David N.

AU - Soudais, Claire

AU - Casanova, Jean Laurent

PY - 2005

Y1 - 2005

N2 - Mutations involving gains of glycosylation have been considered rare, and the pathogenic role of the new carbohydrate chains has never been formally established. We identified three children with mendelian susceptibility to mycobacterial disease who were homozygous with respect to a missense mutation in IFNGR2 creating a new N-glycosylation site in the IFNγR2 chain. The resulting additional carbohydrate moiety was both necessary and sufficient to abolish the cellular response to IFNγ. We then searched the Human Gene Mutation Database for potential gain-of-N-glycosylation missense mutations; of 10,047 mutations in 577 genes encoding proteins trafficked through the secretory pathway, we identified 142 candidate mutations (∼1.4%) in 77 genes (∼13.3%). Six mutant proteins bore new N-linked carbohydrate moieties. Thus, an unexpectedly high proportion of mutations that cause human genetic disease might lead to the creation of new N-glycosylation sites. Their pathogenic effects may be a direct consequence of the addition of N-linked carbohydrate.

AB - Mutations involving gains of glycosylation have been considered rare, and the pathogenic role of the new carbohydrate chains has never been formally established. We identified three children with mendelian susceptibility to mycobacterial disease who were homozygous with respect to a missense mutation in IFNGR2 creating a new N-glycosylation site in the IFNγR2 chain. The resulting additional carbohydrate moiety was both necessary and sufficient to abolish the cellular response to IFNγ. We then searched the Human Gene Mutation Database for potential gain-of-N-glycosylation missense mutations; of 10,047 mutations in 577 genes encoding proteins trafficked through the secretory pathway, we identified 142 candidate mutations (∼1.4%) in 77 genes (∼13.3%). Six mutant proteins bore new N-linked carbohydrate moieties. Thus, an unexpectedly high proportion of mutations that cause human genetic disease might lead to the creation of new N-glycosylation sites. Their pathogenic effects may be a direct consequence of the addition of N-linked carbohydrate.

UR - http://www.scopus.com/inward/record.url?scp=22844449795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22844449795&partnerID=8YFLogxK

U2 - 10.1038/ng1581

DO - 10.1038/ng1581

M3 - Article

VL - 37

SP - 692

EP - 700

JO - Nature Genetics

JF - Nature Genetics

SN - 1061-4036

IS - 7

ER -